Evaluation of the Immunogenicity and Safety of VARIVAX™ in Healthy Russians (V210-058)
Clinical trial NCT03843632 · COMPLETED
Trial details
- NCT number
- NCT03843632
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-01
- Primary completion
- 2020-06-19
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.